REPAGLINIDE
Healthy Adult Participants
Institut de Recherches Internationales Servier (I.R.I.S.)Small moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Healthy Adult Participants cohort.
Same molecule, other indications
REPAGLINIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →